Company Overview: Greenwich LifeSciences (GLSI)
b'Greenwich LifeSciences (GLSI) is a clinical stage biopharmaceutical company that develops immunotherapy treatments for cancer. Snehal Patel, CEO and Board Member of Greenwich LifeSciences, gives an overview of the company, as well as talking about what to know about the GP2 treatment. Greenwich LifeSciences stock is up 10% in 2021. Tune in to find out more.'